Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/n...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/n...